Zhu J S, Halpern G M, Jones K
Department of Pediatrics, Stanford University School of Medicine, California, USA.
J Altern Complement Med. 1998 Fall;4(3):289-303. doi: 10.1089/acm.1998.4.3-289.
This review presents Cordyceps sinensis (Berk.) Sacc., a fungus highly valued in China as a tonic food and herbal medicine. The extant records show the continued use of C. sinensis is now centuries old. The major chemical, pharmacological, and toxicological studies on C. sinensis and the various derived, cultured, fermented mycelial products currently in use are reviewed from the English and Chinese literature. Preclinical in vitro and in vivo studies and clinical blinded or open-label trials in to date over 2000 patients are reviewed. These studies show the main activities of the fungus in oxygen-free radical scavenging, antisenescence, endocrine, hypolipidemic, antiatherosclerotic, and sexual function-restorative activities. The safety of the fungus, its effects on the nervous system, glucose metabolism, the respiratory, hepatic, cardiovascular, and immune systems, immunologic disease, inflammatory conditions, cancer, and diseases of the kidney will be reviewed in the second part of this article to be published in the winter issue of this journal.
本综述介绍了中华虫草菌(Cordyceps sinensis (Berk.) Sacc.),它在中国作为滋补食品和草药备受推崇。现存记录表明,中华虫草菌的持续使用已有数百年历史。本文从英文和中文文献中综述了对中华虫草菌及其目前使用的各种衍生、培养、发酵菌丝体产品的主要化学、药理和毒理学研究。对临床前的体外和体内研究以及迄今针对2000多名患者的临床盲法或开放标签试验进行了综述。这些研究表明,该真菌的主要活性包括清除氧自由基、抗衰老、调节内分泌、降血脂、抗动脉粥样硬化以及恢复性功能。本文第二部分将发表于本杂志冬季刊,将综述该真菌的安全性,及其对神经系统、葡萄糖代谢、呼吸、肝脏、心血管和免疫系统、免疫性疾病、炎症性疾病、癌症和肾脏疾病的影响。